Entrada Therapeutics, Inc. - Common Stock —— 季度资产负债表 (NASDAQ:TRDA) | MetaTrader

展开完整图表完整图表

新闻

Entrada Therapeutics, Inc. (TRDA) Q1 2026 Earnings Call Transcript

Sarepta Dives; Can 2026 Be The Reset Year For Its Controversial Gene Therapy?

Entrada Therapeutics, Inc. (TRDA) Reports Q1 Loss, Misses Revenue Estimates

Entrada Therapeutics (TRDA) Surges 8.9%: Is This an Indication of Further Gains?

Travere Therapeutics (TVTX) Reports Q1 Loss, Misses Revenue Estimates

Entrada Therapeutics Q4 每股收益超出预期, 营收低于预期

Entrada Therapeutics earnings beat by $0.04, revenue fell short of estimates

Arcutis Biotherapeutics, Inc. (ARQT) Surpasses Q4 Earnings and Revenue Estimates

Repligen (RGEN) Tops Q4 Earnings and Revenue Estimates

Earnings Preview: Entrada Therapeutics, Inc. (TRDA) Q4 Earnings Expected to Decline

EyePoint (EYPT) Surges 15.2%: Is This an Indication of Further Gains?

Illumina (ILMN) Tops Q4 Earnings and Revenue Estimates